Fintel reports that on 9 October 2026, Raymond James initiated coverage of Nektar Therapeutics (LSE:0UNL) with a Market Perform recommendation. Nektar Therapeutics is a biopharmaceutical company based ...
A large real-world data study has established sex- and age-stratified reference intervals for serum CA125 using five ...
COA's Nicolas Ferreyros discusses real-world survival data for community oncology, health system consolidation, and barriers to CAR T-cell access. OneOncology's Edward "Ted" Arrowsmith, MD, MPH, ...
Combining tisotumab vedotin with carboplatin, pembrolizumab, and optional bevacizumab produces robust responses in first-line recurrent or metastatic cervical cancer. Roisin E. O’Cearbhaill, MD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results